DCVC Opportunity Fund II GP, LLC

Key Holdings

The sole reported holding is Recursion Pharmaceuticals, Inc. (ticker RXRX, Healthcare):

• Market value: $19.28M
• Shares held: 3.95M
• Implied average price in the filing: approximately $4.88 per share (19.28M / 3.95M)

RXRX comprises 100.0% of the fund’s disclosed 13F portfolio value. The filing marks RXRX as unchanged versus the prior quarter (i.e., the reported position was carried forward rather than increased or newly opened on this 13F). Because the entire reported portfolio is concentrated in one issuer, the filer’s public-equity exposure is fully exposed to RXRX-specific price and company developments.